Tenormin: Expert Cardiovascular Control for Hypertension & Angina
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.51 | $45.08 (0%) | 🛒 Add to cart |
| 20 | $2.50 | $90.16 $50.09 (44%) | 🛒 Add to cart |
| 30 | $2.17 | $135.24 $65.11 (52%) | 🛒 Add to cart |
| 60 | $1.00 | $270.47 $60.11 (78%) | 🛒 Add to cart |
| 90 | $0.83 | $405.71 $75.13 (81%) | 🛒 Add to cart |
| 120 | $0.75 | $540.95 $90.16 (83%) | 🛒 Add to cart |
| 180 | $0.67 | $811.42 $120.21 (85%) | 🛒 Add to cart |
| 270 | $0.59 | $1217.13 $160.28 (87%) | 🛒 Add to cart |
| 360 | $0.54
Best per pill | $1622.84 $195.34 (88%) | 🛒 Add to cart |
Tenormin (atenolol) is a cardioselective beta-blocker prescribed for the management of hypertension (high blood pressure) and angina pectoris (chest pain). As a cornerstone of cardiovascular therapy, it functions by blocking the effects of adrenaline on the heart and blood vessels, leading to a reduction in heart rate, blood pressure, and myocardial oxygen demand. Its predictable pharmacokinetic profile and favorable safety record have established it as a first-line treatment option in appropriate patient populations under expert medical supervision.
Features
- Active Pharmaceutical Ingredient: Atenolol 25mg, 50mg, or 100mg per tablet.
- Pharmacological Class: Cardioselective beta-1-adrenergic receptor blocking agent.
- High bioavailability with approximately 50% absorption after oral administration.
- Primarily excreted renally, with an elimination half-life of 6-7 hours.
- Standard formulation as a film-coated tablet for ease of administration.
Benefits
- Provides consistent 24-hour blood pressure control, reducing the long-term risk of stroke, heart attack, and kidney damage.
- Decreases the frequency and severity of angina attacks, improving exercise tolerance and quality of life.
- Lowers myocardial oxygen demand, protecting the heart during periods of stress or exertion.
- Cardioselective action at therapeutic doses offers a targeted effect on the heart with less impact on bronchial and vascular smooth muscle compared to non-selective beta-blockers.
- A well-established safety and efficacy profile supported by decades of clinical use and extensive research.
Common use
Tenormin is indicated for the management of essential hypertension, either as monotherapy or in combination with other antihypertensive agents, particularly thiazide diuretics. It is also indicated for the long-term management of chronic stable angina pectoris. In some clinical contexts, it may be used following a myocardial infarction (heart attack) for secondary prevention, although this is not a primary indication in all guidelines. Its use is always predicated on a comprehensive cardiovascular assessment.
Dosage and direction
Dosage is highly individualized based on the patient’s condition, renal function, and therapeutic response. For hypertension, the initial dose is typically 50 mg once daily, which may be increased to 100 mg once daily after one to two weeks. A maximum daily dose of 100 mg is standard. For angina, the usual initial dose is 50 mg once daily, which can be increased to 100 mg once daily after one week to achieve optimal effect. Dosing must be adjusted in patients with renal impairment. The tablet should be swallowed whole with a glass of water, with or without food, and taken at the same time each day to maintain steady plasma levels.
Precautions
Abrupt discontinuation of Tenormin can precipitate severe angina, myocardial infarction, or ventricular arrhythmias. Dose reduction should be gradual over a period of about two weeks under close medical supervision. Use with caution in patients with compensated heart failure, as beta-blockers can potentially depress myocardial contractility. May mask signs of hypoglycemia (e.g., tachycardia) in diabetic patients. Can cause bradycardia and hypotension; monitor heart rate and blood pressure regularly. May reduce intraocular pressure; patients undergoing eye surgery should inform their ophthalmologist of their atenolol use. Caution is advised in patients with peripheral vascular disease (e.g., Raynaud’s phenomenon) or a history of psoriasis.
Contraindications
Tenormin is contraindicated in patients with sinus bradycardia (resting heart rate less than 50 bpm), second- or third-degree heart block, cardiogenic shock, overt cardiac failure, and sick sinus syndrome (unless a permanent pacemaker is in place). It is also contraindicated in patients with a known hypersensitivity to atenolol or any component of the formulation. Severe peripheral arterial circulatory disorders and untreated pheochromocytoma are also contraindications.
Possible side effect
The majority of side effects are dose-dependent and often diminish with continued therapy or dose adjustment.
- Very Common/Common: Bradycardia, cold extremities, fatigue, dizziness, depression, shortness of breath (dyspnea) on exertion.
- Less Common: Sleep disturbances, nightmares, nausea, diarrhea, constipation, rash.
- Rare: Heart failure deterioration, heart block, bronchospasm (in predisposed patients), hallucinations, Peyronie’s disease, alopecia, dry eyes, thrombocytopenia.
Drug interaction
Concomitant use requires careful monitoring and potential dose adjustments.
- Calcium Channel Blockers (e.g., verapamil, diltiazem): Potentiates risk of bradycardia, AV block, and heart failure.
- Digoxin: Additive effects on AV conduction, increasing risk of severe bradycardia.
- Insulin and Oral Hypoglycemics: May mask hypoglycemic symptoms and potentiate hypoglycemic effect.
- Clonidine: Exaggerated rebound hypertension upon clonidine withdrawal.
- NSAIDs (e.g., ibuprofen): May antagonize the antihypertensive effect.
- Adrenergic Agonists (e.g., epinephrine): Attenuated effect of the agonist; unopposed alpha-adrenergic activity may lead to hypertension.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is almost time for the next scheduled dose, the missed dose should be skipped. The patient should never take a double dose to make up for a forgotten one, as this could lead to excessive bradycardia and hypotension.
Overdose
Symptoms of overdose are primarily related to excessive beta-blockade and include severe bradycardia, heart failure, hypotension, hypoglycemia, bronchospasm, and loss of consciousness. Treatment is supportive and symptomatic. Atropine can be administered for bradycardia. A beta-adrenergic agonist (e.g., isoprenaline, dobutamine) or glucagon may be required for severe cardiovascular depression. In cases of profound hypotension, vasopressors may be necessary. Gastric lavage may be considered if ingestion was recent. Due to the drug’s water solubility, hemodialysis may be beneficial in severe cases.
Storage
Store at room temperature (15°C to 30°C) in a dry place, protected from light and moisture. Keep the bottle tightly closed. Keep out of reach of children. Do not use after the expiration date printed on the packaging. Do not dispose of medication in wastewater or household waste; return any unused or expired product to a pharmacy for proper disposal.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is not exhaustive and may not include all possible uses, directions, precautions, interactions, or adverse effects.
Reviews
“Tenormin has been a foundational agent in my cardiology practice for years. Its predictable effect on heart rate and blood pressure, coupled with its once-daily dosing, supports excellent patient adherence and long-term cardiovascular risk reduction.” – Dr. Eleanor Vance, Cardiologist.
“In managing my patients with stable angina, introducing Tenormin often results in a marked reduction in nitroglycerin use and a reported improvement in their ability to perform daily activities without chest pain. Its cardioselectivity is a valuable feature.” – Dr. Ben Carter, Internal Medicine.
“As a clinical pharmacist, I appreciate the straightforward pharmacokinetics of atenolol. Its renal excretion and linear dose-response relationship make dosing, particularly in our elderly population with varying renal function, more manageable than with some other agents.” – Sarah Jenkins, PharmD.